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ECG measurement parameters of athletes are reliable
when made with a smartphone based ECG device
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ABSTRACT
Athletic pre-participation cardiac screening including electrocardiogram (ECG) is
a subject of controversy among sports medicine practitioners. Opponents of preparticipation ECG screening cite concerns regarding the cost and accuracy of the
testing. Recently, a single lead ECG accessory has become available for use with
smartphones. The purpose of this study was to evaluate the between and within rater
validity and reliability of the Kardia device in recording the ECG parameters rate, rhythm,
and PR, QRS, QT intervals. The ECG parameters recorded with the smartphone were also
compared to same measures made using a 12 lead electrocardiograph.
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This investigation used a repeated measures cross-sectional design. The investigation
was conducted in two separate phases using separate participant samples. Phase 1
(N=10) was used to determine the within rater reliability with the Kardia device. Phase 2
(N=12) was used to determine the reliability between the Kardia device and the 12 lead
electrocardiograph.
The between rater and between device reliability for the rate, QT interval and QRS
duration parameters ranged good to very good (ICC = 0.667 – 0.981). The current
investigation showed that the reliability of the ECG parameters measured using the
smartphone technology ranged from good to very good. This paper serves as support
for a technological advancement that will help advance the debate on the utility of ECG
testing as part of the athletic pre-participation physical.
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INTRODUCTION

medicine physicians.

Sudden cardiac death (SCD) is an uncommon yet
tragic problem that exists in competitive athletics. In
the United States, the incidence of SCD amongst high
school and collegiate athletes is estimated to be 1 in
200,000, with hypertrophic cardiomyopathy (HCM)
the most common killer (36%).1 Approximately 5%
of SCD are attributed to arrhythmias such as long QT
syndrome (LQT), Wolff-Parkinson-White syndrome
(WPW), and Brugada syndrome.1 Identification
of these electrical disorders in an athletic patient
has been the topic of discussion amongst sports

The pre-participation cardiac screen including
electrocardiogram (ECG) is a subject of controversy
among sports medicine practitioners.2 Some sports
medicine practitioners advocate that the benefits
of pre-participation screening including ECG do not
justify the risks of false positive test results leading
to unnecessary additional workup and lost sport
time.2 Opponents of mass ECG screening have their
argument buttressed by studies that demonstrate
the difficulty in consistent and correct interpretation
of an athlete’s ECG, across interpreters of varying
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medical specialty and education.3 This can lead to a
relatively high rate of false-positive interpretations
and unnecessary secondary evaluations.3,4
A compelling contrary viewpoint based on
evolving knowledge of ECG interpretation and its
implementation in the athletic setting has been
identified. A recent systematic review and metaanalysis of fifteen papers (over 47,000 athletes) found
ECG screening has a significantly higher sensitivity
and a lower false positive rate than history or physical
exam alone.5 To further strengthen the argument for
the use of ECG in pre-participation screening there
is opinion across many levels of sport internationally
that the mass implementation of ECG has benefit for
the athletic population.6 The increasing use of ECG
in the pre-participation cardiac screening calls for
improved agreement in the criteria used to interpret
the ECG of the athlete.
To improve ECG interpretation, the European Society
of Cardiology (ESC) developed recommendations
for physicians to use when analyzing the ECG of
athletes.7 The ESC’s recommendations decreased the
errors seen between physicians when interpreting
the ECG of athletes.
In 2013 the Seattle Criteria were developed with
the hope to further decrease the variability of the
ECG interpretations of athletes.8 The Seattle Criteria
utilizes a checklist of findings to guide physicians in
ECG interpretations.8 This checklist includes the same
criteria as of the European Cardiology Society, as well
as expands the guidelines for diagnosis of several
electrical disorders of the heart. In 2014 the Refined
Criteria created guidelines using a combination of
the guidelines of European Cardiology Society and
Seattle Criteria, and added some new boundaries.
The frequency of abnormal ECG readings have
decreased with the use of each criteria: European
Cardiology Society 22%, Seattle Criteria 11.6%,
Refined Criteria 5.3%.9 This demonstrates that Refined
Criteria has had the most success in decreasing false
positives in ECG interpretation by combining the
most effective aspects of each criteria system and by
standardizing interpretation techniques.
More recently, a newer evaluation protocol has
evolved. The International Criteria published in
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March 2017 is an amalgam of the best evidence to
date.10 It has been endorsed by many governing
bodies, including the American Medical Society for
Sports Medicine, International Olympic Committee,
European Society of Cardiology, and the American
College of Cardiology. The International Criteria
provides a consensus protocol from which those
practicing within the field of cardiologic sports
medicine should take direction. Among other items,
it provides an algorithm for interpretation of ECG
within the athletic subset defining findings as either
“normal,” “abnormal,” or “borderline”.
In light of the development of the International
Criteria, reducing the burden associated with ECG
collection and interpretation may be an effective
strategy to make ECG screening more practical for
application in athletic screening. This is especially
important in the current sports medicine climate.
Due to unfortunate tragedy associated with
undiagnosed arrhythmias and a perceived lack in
resource utilization, it is the authors’ belief that it
is incumbent upon physicians practicing within
the athletic population to strongly consider the
implementation of ECG screening during preparticipation physical examination.
Smartphone based technology for ECG screening
might further reduce the burden of mass ECG
screening. Recently, a single lead ECG accessory
(Kardia, AlivCore, San Francisco, CA) has become
available for use with smartphones. This device
is capable of recording a single lead ECG
corresponding to leads I, II, or an anterior precordial
lead depending on its placement upon the body.
The application of this device in various populations
and cardiac conditions has been investigated.11-18
The Kardia device could represent a cost-effective
alternative to the standard 12 lead ECG in detecting
life-threatening arrythmogenic pathology where a
rhythm strip may be sufficient to detect pathology,
such as WPW, LQT, Brugada, etc. The reduced cost
and the increased ease of use of these devices will
likely lead to an increase in the use of smartphone
integrated ECG recording devices by sports medicine
providers, in turn leading to greater variability in the
level of medical training of the medical practitioner
that are interpreting and applying the results of the
ECG screening.
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The purpose of this investigation was to evaluate
the validity and reliability of the Kardia device
in measuring rate, rhythm, and the PR, QRS, and
QT intervals on ECG strips collected using the
Kardia device. We explored the consistency of the
interpretation of the ECG amongst clinicians with
varied training. The authors hypothesize that the
Kardia device will perform comparably to a standard
12 lead ECG and that there will not be a statistically
significant difference in the interpretation amongst
clinicians beyond the accepted differences already
acknowledged.
METHODS
Three physicians participated in this investigation:
a fellowship trained primary care sports medicine
physician, a pediatric cardiologist, and a family
medicine physician. Of these three physicians, two
were well practiced and aware of the controversy
and varying methods of ECG interpretation for
the athletic subset. The project was conducted in
two phases. The goal of phase 1 was to determine
the consistencies of the ECG measures within and
between raters. Phase 2 determined the consistency
of the ECG measures made between a smartphone
ECG base device and a traditional 12 lead ECG in
athletes. For phase 1 the ECG was collected from ten
volunteers (8 male, 2 female); all were healthy and
did not have a history of cardiac disease or injury.
For phase 2 ECG data was collected from 12 healthy
intercollegiate male basketball athletes of a similar
age range to that of phase 1 group. All participants
provided written informed consent prior to data
collection procedures. The current study was
approved by the Marshall University Internal Review
Board (IRBNet ID# 826364-1).
Phase 1
The ECG signals were collected using the
smartphone based Kardia (AliveCor Inc., San
Francisco, CA, USA). One ECG strip was recorded
from each participant, 2 copies of each strip were
provided to each rater for interpretation.
Phase 2
The ECG signals were collected using 2 devices, the
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smartphone based Kardia and a traditional 12 lead
ECG device (Marquette Case 2, GE Medical Systems,
Milwaukee, WI, USA). Raters were presented with 1
copy of the ECG strip from each device
The ECG collection protocol was the same for
both devices. The ECG signal was collected for 60
seconds and analysis was performed on the middle
30 seconds of each ECG strip. Participants sat
quietly for five minutes prior to the data collection.
Data from each device was collected following
the manufacturer’s instructions by a clinician
experienced and trained with the use of each device.
All data was collected by the same investigator to
ensure consistency. Following collection each ECG
strip was identified by a coded identifier number.
Lead 1 from the 12 lead and Kardia was used for
analysis; lead 1 was chosen due to the ease of
collection of lead 1 from the Kardia device. The
identification of each ECG strip was removed and
replaced by a random identifier prior to ECG analysis.
Each rater analyzed all ECG strips. The ECG strips
were presented to each rater in predetermined
random order; random order was different for each
rater. All rater were blinded to any output other than
the ECG tracing and the measurements made by
the other raters. Each rater measured rate, rhythm
and the PR, QRS, and QT intervals of all ECG strips.
The ECG parameters were measured to the nearest
millisecond using guidelines based on the rater’s
specific training in ECG analysis. Raters recorded
their measurements on paper data collection forms.
Data was collated and entered into the database by
the investigator that assigned the random identifier.
Data analysis was performed by an investigator that
was not active in the assessment in the ECG strips.
Statistical Analysis
The reliability of measures was determined using
the Interclass Correlation coefficient (Model 2) for
the continuous measures (rate, QT interval and QRS
duration) and the Kappa statistic for the nominal
data. Bland-Altman plots were produced in order
to assess for systematic error.19 The difference
between the first and second measurement for
all continuous variables was calculated, a single
sample t test was used to test if the differences were
different than zero. All statistical calculations were
performed using SPSS 22 (SPSS, Chicago, IL), and
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statistical significance was determined at p<0.05.
Intraclass correlation coefficients [ICC (2-way fixed)]
was used to determine the inter-rater reliability of
the continuous variables (rate, QT interval and QRS
duration). The ICC value is considered very good for
values 0.81–1.00, good for 0.61–0.80, moderate for
0.41–0.60, fair for 0.21 – 0.40, and poor for values
below 0.20.20 The kappa statistic greater than 0.80
is considered as representing excellent agreement,
0.60–0.79 substantial agreement, 0.40–0.59
moderate agreement.20 Measurement error was
calculated with the standard error of measure (SEM)
= standard deviation x [√(1 - ICC)], which estimates
the error about a single measure of a variable. The
minimal detectable change (MDC) represents the
error when a measure is taken twice (change over
time), and was calculated by multiplying the SEM by
the square root of 2.21,22

= 0.533 – 0.940), QRS (ICC = 0.667, 95%CI = 0.287 –
0.897), and QT (ICC = 0.790, 95%CI = 0.509 – 0.938)
intervals showed good reliability. The within rater
ICC, SEM, and MDC values are presented in table 2.
Collapsed across all raters, the agreement of the
cardiac rhythm between the 2 strips showed
substantial agreement (kappa = 0.692, p < 0.01).
Individually the raters showed moderate to excellent
agreement: rater 1 showed excellent agreement
(kappa = 1.00, p = 0.01), rater 2 (kappa = 0.615, p =
0.03) and rater 3 (kappa = 0.583, p = 0.01) showed
moderate agreement. Bland-Altman plots (Figure
1) do not show a systematic bias with any of the
parameter measures. The differences between the
first and second measurements were not statistically
different (p > 0.05) from zero for any of the
parameters measured.
P hase 2

RESULTS
Phase 1
The between rater ICC for the heart rate showed
excellent reliability (ICC = 0.981, 95%CI 0.955 – 0.995)
across the three raters. (Table 1)
The between rater ICC for the PR (ICC = 0.798, 95%CI

TABLE 1. Between rater measurement parameters, Phase 1

The reliability of the measures between devices
ranged from good to excellent (ICC = 0.678 – 0.980).
The between device ICC values ranged from poor to
excellent; ICC, SEM, and MCD are presented in table
3.
The within rater ICC, SEM, and MDC values are
presented in table 4.
Collapsed across all raters there was
moderate agreement (kappa = 0.467, p
< 0.01) for rhythm between the devices.
The agreement for individual raters was
varied; rater one showed poor agreement
(kappa = 0.153, p = 0.40), rater two
moderate agreement (kappa = 0.455, p =
0.02) while rater three rated all subjects
as have a normal sinus rhythm based
on the ECG strips collected from both

TABLE 2. Within rater measurement parameters, Phase 1
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FIGURE 1. Bland-Altman plots for the repeated Alivcore measures, rate (top left), PR interval
(top right), QRS interval (bottom left), QT (interval bottom right).

TABLE 3. Between device measurements parameters, collapsed across raters Phase 2

TABLE 4. Within rater measurement parameters, phase 2
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FIGURE 2. Bland-Altman plots for the between device comparisons, rate (top left), PR interval
(top right), QRS interval (bottom left), QT (interval bottom right).

devices. Visual evaluation of the Bland-Altman plots
shows an apparent systematic bias for the rate and
the PR interval. The difference in the rate measures
(mean difference 2.1±4.7 bpm, t=-2.636, p = 0.01)
and QRS interval (mean difference = 7.71±18.5ms,
t = -469, p = 0.02) between the Kardia and 12 lead
were statistically different from zero. The Kardia
measurement was higher than the measurement
made using the 12 lead, suggesting that the values
were consistently overestimated when using the
Kardia. The Bland-Altman plots (Figure 2) for the PR
and QRS intervals showed a random distribution of
the difference between the devices.
DISCUSSION
The current investigation showed that the reliability
of the ECG parameters measured using the
smartphone technology ranged from good to very
good. When reliability within each clinician was
explored the reliability decreased particularly for
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the QRS and QT interval measures. None of the
data analysis included QTc. With respect to QRS, it
is reasonable to assert that this difference is due to
the narrow measurement window. A difference of
0.05 milliseconds could skew data points widely. It
is important to note that none of the interpreters
measured QT or QRS to be “abnormal”.
The reliability of the ECG parameters between
the devices ranged from fair to very good when
calculated collapsed across the clinicians. The
reliability decreased when calculated between
the clinicians. The greatest decreases were found
for the interval measures. The difference in the
reliability amongst the clinicians may suggest that
the clinician’s level of training and experience with
interpreting ECG strips affects the consistency of
these measurements. The systematic errors revealed
in the rate and QRS interval measures between
the two devices might also suggest that there are
differences in the responsiveness of the devices.
At the time of testing all participants were healthy
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TABLE 5. The 95% confedence intervals for age related
normal values and values measured uisng the Kardia wirerless device.

with no known cardiac conditions. No abnormal
findings were found during testing for the current
study. The 95% confidence interval for all of the
smartphone measured ECG parameters fell within the
95% confidence intervals for the published age based
norms (Table 5).23
No parameter measures exceeded the limits of
European or Seattle Criteria. The results from the
twelve basketball players would not produce false
positive tests with respect to this single lead.
This paper had many limitations. Given the small
sample size of this investigation, readers must
apply the results with caution. Stronger conclusions
could be made if the investigation was duplicated
utilizing larger sample sizes. Utilization of a single
lead as a screening device during pre-participation
examination is not an accepted practice nor one
that is being advocated for by any medical body at
the time of this writing. Even the most basic ECG
screening requires multiple anatomical leads for
analysis, not solely a rhythm strip. It is the opinion
of the authors that the use of the Kardia device is
not to be advocated for in the pre-participation
setting unless solely looking for the aforementioned
arrythmogenic pathologies. The authors believe
there is a definite role for its use in the on-field/
athletic training clinic setting to rule out acute events
such as arrhythmia. It is impossible to assert from the
current investigation its efficacy in such a setting nor
was it the intention of this study to do so.
Another limitation that was seen in this study echoes
the known patterns of error associated with ECG
interpretation.24 Discrepancies in interpretation were
seen across the three subspecialties represented
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within the study. Whether this is from
the narrow measurement difference
resulting in broad statistical difference,
interpreter error, or variability within
the smartphone device is unknown. The
latter argument is made less likely by the
fact that these problems are pervasive in
the traditional ECG environment already.3
It is the opinion of the authors that the
current study helps to validate the limited data this
smartphone device is able to relay to the interpreter.
The implementation of ECG screening within the
athletic setting remains controversial. The current
investigation showed that the reliability of the
ECG parameters measured using the smartphone
technology ranged from good to very good.
This paper serves as support for a technological
advancement that will help advance the debate
on the utility of ECG testing as part of the athletic
pre-participation physical. Evolution in technology
will continue to allow for arguments for and against
the utility of pre-participation ECG screening. This
evolution of ECG technology may introduce new
variables and create new quandaries. The same
trends seen in generally accepted means of preparticipation ECG screening can be seen within this
study.23 Further advancements in improvement
in consistent interpreter quality, availability of
measuring devices, and the reduction of burden
associated with further work up following a positive
ECG screen have been and remain necessary.
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